Diabetes risk assessment in Polish community pharmacies. Results from a pilot national screening campaign
Open Access
- 8 January 2026
- journal article
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 22 (1) , 527-530
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- May Measurement Month 2022: results from the global blood pressure screening campaignBMJ Global Health, 2024
- Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2022
- Qualitative exploration of the experiences of community pharmacists delivering the Diabetes MedsCheck serviceJournal of Clinical Pharmacy and Therapeutics, 2022
- Prediabetes, undiagnosed diabetes and diabetes risk in Italy in 2017–2018: results from the first National screening campaign in community pharmaciesJournal of Public Health, 2021
- Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility studyBMJ Open, 2019
- Pharmacists as accessible primary health care providers: Review of the evidenceCanadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2018
- Gender influence on health and risk behavior in primary prevention: a systematic reviewJournal of Public Health, 2017
- Community pharmacy type 2 diabetes risk assessment: demographics and risk resultsInternational Journal of Pharmacy Practice, 2014
- How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohortDiabetologia, 2012